Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
Clinical trial NCT03715322 · UNKNOWN
Trial details
- NCT number
- NCT03715322
- Sponsor
- Guangzhou Institute of Respiratory Disease
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2021-04-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.